QR code

Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia

Objective: BCR-ABL1 kinase domain (KD) mutations can lead to resistance to first- and second-generation tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML). Here, we present the first report of the spectrum of mutations in the BCR-ABL1 KD of CML patients from Azerbaijan.Materials and...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Aypara Hasanova, Chingiz Asadov, Nigar Karimova, Aytan Shirinova, Gunay Aliyeva, Zohra Alimirzoyeva
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2023-12-01
Reeks:Pathology and Oncology Research
Onderwerpen:
chronic myeloid leukemia
mutation
tyrosine kinase inhibitor resistance
kinase domain
BCR-ABL
Online toegang:https://www.por-journal.com/articles/10.3389/pore.2023.1611518/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items